Dutasteride 0.5 mg Tablet

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is needed in patients with renal impairment or elderly patients. The recommended dose in patients with hepatic impairment has not been established because there are no data on administration of this medicine to these patients.

This medication can be absorbed through the skin, so women who are pregnant or may become pregnant should avoid touching or handling it. In particular, contact with broken or crushed pieces of this medication should be avoided, and precautions should be taken to ensure that children do not touch broken pieces of it. This medication is not to be administered to women or children under 18 years of age. Patients with hypersensitivity or allergies to this medication or similar drugs should also avoid its use. Adult men planning to conceive should use this medication cautiously as it may affect fertility; usage should be determined by a doctor's judgment. Patients with urinary tract issues or poor liver function should be cautious when using this medication, and especially careful administration is required for those with liver disorders. Caution is necessary when taken with strong CYP3A4 inhibitors as it may alter the drug concentration. During treatment, erectile dysfunction, decreased libido, and semen disorders may occur, and these symptoms may persist even after discontinuation. Breast-related adverse reactions such as breast tenderness or gynecomastia have also been reported. Long-term use may increase the risk of high-grade prostate cancer; therefore, regular prostate examinations and monitoring of PSA levels are necessary. Blood donation is prohibited for at least 6 months during the use of this medication to prevent the medication from being passed to pregnant women. There are no specific antidotes for overdose, so appropriate supportive treatment based on symptoms is necessary. This medication should be kept out of reach of children and stored in its original container to prevent misuse or quality degradation. It is known not to affect driving or the ability to operate machinery, but caution is required as individual responses may vary. Pregnant women or nursing mothers should not use this medication as its safety has not been established. Patients receiving this medication should be regularly evaluated for prostate cancer and other urological diseases, and it is important to consult a doctor regarding changes in PSA levels.

• Erectile dysfunction
• decreased libido
• ejaculation disorder
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorder
• dizziness
• rash

This medication should be stored in a tightly sealed container to prevent exposure to air and kept at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's effectiveness for a longer period.

Appearance

Pale yellow, oval-shaped film-coated tablet

Package unit

30 tablets/PTP[((10 tablets/PTP) x 3)]